MoneyWorks4Me

Godavari Drugs - Quaterly Results

12 Feb 2026 Evaluate
The sales declined to Rs. 221.84 millions for the December 2025 quarter as compared to Rs. 295.52 millions during the corresponding quarter last year.The Company's Net profit for the December 2025 quarter have declined marginally to Rs. 7.58  millions as against Rs. 7.67 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 24.94 millions from 26.75 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 221.84 295.52 -24.93 726.44 878.48 -17.31 1133.50 1567.12 -27.67
Other Income 0.16 0.98 -83.67 6.63 8.72 -23.97 9.77 6.18 58.09
PBIDT 24.94 26.75 -6.77 80.39 95.87 -16.15 128.04 139.22 -8.03
Interest 11.11 11.10 0.09 30.24 36.25 -16.58 47.32 49.15 -3.72
PBDT 16.34 15.65 4.41 52.66 59.62 -11.67 80.72 89.17 -9.48
Depreciation 6.12 6.44 -4.97 18.20 17.76 2.48 24.48 19.95 22.71
PBT 10.22 9.21 10.97 34.46 41.86 -17.68 56.24 69.22 -18.75
TAX 2.64 1.54 71.43 6.47 6.99 -7.44 12.45 13.73 -9.32
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 7.58 7.67 -1.17 27.99 34.87 -19.73 43.79 55.49 -21.08
Equity 75.30 75.30 0.00 75.30 75.30 0.00 75.30 75.30 0.00
PBIDTM(%) 11.24 9.05 24.20 11.07 10.91 1.40 11.30 8.88 27.15
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..